| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1773308656.M818724P6870.host100322.itwesthosting.com,S=17521,W=17763 |
Return-Path: <newsletter@enews.abnova.com.tw>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id cBmqMPCKsmnWGgAAp0YrwQ
(envelope-from <newsletter@enews.abnova.com.tw>)
for <ithome@host100322.itwesthosting.com>; Thu, 12 Mar 2026 10:44:16 +0100
Return-path: <newsletter@enews.abnova.com.tw>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Thu, 12 Mar 2026 10:44:16 +0100
Received: from mail93231.spmail6.com ([103.230.32.231]:37594 helo=smtp93231.spmail6.com)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <newsletter@enews.abnova.com.tw>)
id 1w0caW-0001pO-0D
for senka.rendulic@bolnica-lipik.hr;
Thu, 12 Mar 2026 10:44:16 +0100
Received: from WIN-U5BVQFM8LB2 (unknown [103.95.59.1])
by smtp93231.spmail6.com (Postfix) with ESMTPA id 7D149413EA88
for <senka.rendulic@bolnica-lipik.hr>; Thu, 12 Mar 2026 17:09:39 +0800 (HKT)
DKIM-Signature:v=1; a=rsa-sha1; c=relaxed/relaxed; d=enews.abnova.com.tw; s=intl;
q=dns/txt; h=From:Subject:Date:To; bh=1niBRR8AI0ZodPAzbzUxo3qbkzU=;
b=A5/XlZ3ZQxqUp1DWJNZUgn6AMpY4jDmQIWPU5ouBDqfQnLR+/9C33o8oI8Bood4EVygDDd
rg65JoJqyKXO/lQPtTABk5dojAUeIAN+nZrmbeSr5qg1aNj0OWgpLqntc5bcVeEuydisREQ
9FxSN0YH4UqVtyxcm8TTOahWehvLCM=;
DomainKey-Signature: a=rsa-sha1; c=simple; q=dns; d=enews.abnova.com.tw; s=intl;
h=From:To:Sender:Date:Subject:MIME-Version:Content-Type:X-Mailer:X-Spre
ad-CampaignId:X-Spread-SubscriberId:X-Spread-SpreaderId:X-Spread-Engine
-Build:List-Unsubscribe:Message-ID;b=Iov+vb0AX5Oym/l/UDoT+ooCMs02HqF3pIH0UVd4Rx6FR/Pc5qRTYPKFXr7JI93QV3iDX
c+03Up0IiYB9Bugc7VDquSTPwqWdktbF0M0XsOuuQ7gWclaHL55spOny7LZQqUugPq9Ro8C
vmzOZFeQeGXgafM2JFF0ctgO+UScjBw=;
From: "Abnova" <newsletter@enews.abnova.com.tw>
To: "senka.rendulic@bolnica-lipik.hr" <senka.rendulic@bolnica-lipik.hr>
Sender: <newsletter@enews.abnova.com.tw>
Date: Thu, 12 Mar 2026 16:58:18 +0800
Subject: =?UTF-8?B?Uk5BLUVuY29kZWQgVkhIIGZvciBFbWVyZ2luZyBBcHBsaWNhdGlvbnM=?=
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="_=aspNetEmail=_d414753d06d149708116fb5c91742784"
X-Mailer: aspNetEmail ver 3.7.0.19
X-Spread-CampaignId: 8425638
X-Spread-SubscriberId: 217861858
X-Spread-SpreaderId: 85453
X-Spread-Engine-Build: 7.2.10.0
List-Unsubscribe: <mailto:abuse@mail.spread6.net?subject=sub/217861858/user/85453/campid/8425638/type/e>, <https://enews.abnova.com.tw/Unsubscribe.aspx?sub=217861858&user=85453&campid=8425638&type=e>
Message-ID: <WIN-U5BVQFM8LB2cef55bef0c7c45feabce237c468e3cd7@WIN-U5BVQFM8LB2>
X-Spam-Status: No, score=2.8
X-Spam-Score: 28
X-Spam-Bar: ++
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: 202603_RNA-Encoded_VHH_for_Emerging_Applications Manage Preferences
| Unsubscribe
Content analysis details: (2.8 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: abnova.com.tw]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[103.230.32.231 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[103.230.32.231 listed in sa-accredit.habeas.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.1 TRACKER_ID BODY: Incorporates a tracking ID number
0.7 MPART_ALT_DIFF BODY: HTML and text parts are different
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
0.0 MIME_HTML_ONLY_MULTI Multipart message only has text/html MIME
parts
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--_=aspNetEmail=_d414753d06d149708116fb5c91742784
Content-Type: text/html;
charset="us-ascii"
<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>202603_RNA-Encoded_VHH_for_Emerging_Applications</title>
<style type="text/css">
body {
font-size: 12px;
-webkit-text-size-adjust: none;
}
table {
border-collapse: collapse;
mso-table-lspace: 0pt;
mso-table-rspace: 0pt;
border: 0;
}
span { margin: 0px; }
body {
width: 100% !important;
-webkit-text-size-adjust: 100%;
-ms-text-size-adjust: 100%;
margin: 0 auto;
padding: 0;
}
#body-layout {
margin: 0 auto;
padding: 0;
width: 100% !important;
line-height: 100% !important;
font-family: arial, sans-serif;
}
..page_wrap { margin: 0 auto; min-height: 200px; }
@media screen and (max-width:580px) {
.table_content { width: 100% !important; }
.mobile_hidden { display: none !important; }
.responsive-img { width: 100% !important; height: auto !important; }
}
</style>
</head>
<body bgcolor="#ffffff">
<div class="page_wrap">
<table width="100%" align="center" class="table_content" style="clear:both;margin: 0 auto;" bgcolor="#ffffff" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td align="center" style="font-family:Arial, Helvetica, sans-serif;">
<table width="710" align="center" class="table_content" bgcolor="#ffffff" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>
<table width="100%" cellpadding="0" cellspacing="0" border="0" class="table_content" bgcolor="#004d9f" style="background-color: #004d9f;">
<tbody>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689376/Default.aspx" target="_blank"><img alt="Abnova" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Header_01.jpg" width="238" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689377/Default.aspx"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Header_02.jpg" width="472" style="display: block;" border="0"></a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table width="710" border="0" cellpadding="0" cellspacing="0" class="table_content">
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_01.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_02.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_03.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_04.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_05.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689378/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_06.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689379/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_07.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
</tr>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689380/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_08.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689381/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_09.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
</tr>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689382/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_10.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689383/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_11.jpg" width="355" style="display: block;" border="0" class="responsive-img"></a></td>
</tr>
<tr>
<td colspan="2" style="font-size: 0; line-height: 0px;">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/202603_RNA-Encoded_VHH_for_Emerging_Applications_12.jpg" width="710" style="display: block;" border="0" class="responsive-img"></td>
</tr>
</table>
</td>
</tr>
<tr>
<td>
<table width="100%" cellpadding="0" cellspacing="0" border="0" class="table_content" bgcolor="#004d9f" style="background-color: #004d9f;">
<tbody>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689376/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_01.jpg" width="208" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689384/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_02.jpg" width="43" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689385/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_03.jpg" width="37" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="mailto:sales@abnova.com" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_04.jpg" width="43" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689386/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_05.jpg" width="39" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689387/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_06.jpg" width="36" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689388/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_07.jpg" width="36" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689389/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_08.jpg" width="41" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8425638/639081566354717735/images/Abnova_Ad_Footer_09.jpg" width="227" style="display: block;" border="0"></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td align="right" style="font-size: 14px; font-family: arial; color: #666666; padding: 10px 0;">
<span style="line-height: 18px; font-family: arial, helvetica, sans-serif; font-size: 14px; color: #666666;">
<a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8425638/linkid/1689390/Default.aspx" style="color: #666666; text-decoration: none;" target="_blank">Manage Preferences</a> |
<a href="https://enews.abnova.com.tw/Unsubscribe.aspx?sub=217861858&user=85453&campid=8425638&type=h" target="_blank" style="color: #666666; text-decoration: none;">Unsubscribe</a>
</span>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</body>
</html>
<img src="https://enews.abnova.com.tw//o.aspx/s/217861858/c/8425638" width="1" height="1" />
--_=aspNetEmail=_d414753d06d149708116fb5c91742784--